These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 36923958)

  • 61. Cardio-Oncology: Mechanisms, Drug Combinations, and Reverse Cardio-Oncology.
    Liang Z; He Y; Hu X
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142538
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Big Data and Artificial Intelligence Modeling for Drug Discovery.
    Zhu H
    Annu Rev Pharmacol Toxicol; 2020 Jan; 60():573-589. PubMed ID: 31518513
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cardio-Oncology: Managing Cardiovascular Complications of Cancer Therapies.
    Sharma R; Kashyap J; Olanrewaju OA; Jabbar A; Someshwar F; Saeed H; Varrassi G; Qadeer HA; Kumar S; Cheema AY; Khatri M; Wazir M; Ullah F
    Cureus; 2023 Dec; 15(12):e51038. PubMed ID: 38269231
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cardio-oncology: a multidisciplinary approach for detection, prevention and management of cardiac dysfunction in cancer patients.
    Tajiri K; Aonuma K; Sekine I
    Jpn J Clin Oncol; 2017 Aug; 47(8):678-682. PubMed ID: 28505345
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Age-Related Considerations in Cardio-Oncology.
    Screever EM; Meijers WC; Moslehi JJ
    J Cardiovasc Pharmacol Ther; 2021 Mar; 26(2):103-113. PubMed ID: 33124480
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cardio-oncology - strategies for management of cancer-therapy related cardiovascular disease.
    Totzeck M; Schuler M; Stuschke M; Heusch G; Rassaf T
    Int J Cardiol; 2019 Apr; 280():163-175. PubMed ID: 30661849
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Multimodality Imaging for Cardiotoxicity: State of the Art and Future Perspectives.
    Artico J; Abiodun A; Shiwani H; Kurdi H; Chen D; Tyebally S; Moon JC; Westwood M; Manisty CH
    J Cardiovasc Pharmacol; 2022 Oct; 80(4):547-561. PubMed ID: 35522143
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cardiovascular imaging in cardio-oncology.
    Mahabadi AA; Rischpler C
    J Thorac Dis; 2018 Dec; 10(Suppl 35):S4351-S4366. PubMed ID: 30701103
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Summary of Cardiac Computed Tomographic Imaging in Cardio-Oncology: An Expert Consensus Document of the Society of Cardiovascular Computed Tomography.
    Wright JL; Amini A; Bergom C; Milgrom SA
    Pract Radiat Oncol; 2023; 13(6):488-495. PubMed ID: 37923491
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Nuclear cardio-oncology: From its foundation to its future.
    Kahanda MG; Hanson CA; Patterson B; Bourque JM
    J Nucl Cardiol; 2020 Apr; 27(2):511-518. PubMed ID: 30788760
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC).
    Čelutkienė J; Pudil R; López-Fernández T; Grapsa J; Nihoyannopoulos P; Bergler-Klein J; Cohen-Solal A; Farmakis D; Tocchetti CG; von Haehling S; Barberis V; Flachskampf FA; Čeponienė I; Haegler-Laube E; Suter T; Lapinskas T; Prasad S; de Boer RA; Wechalekar K; Anker MS; Iakobishvili Z; Bucciarelli-Ducci C; Schulz-Menger J; Cosyns B; Gaemperli O; Belenkov Y; Hulot JS; Galderisi M; Lancellotti P; Bax J; Marwick TH; Chioncel O; Jaarsma T; Mullens W; Piepoli M; Thum T; Heymans S; Mueller C; Moura B; Ruschitzka F; Zamorano JL; Rosano G; Coats AJS; Asteggiano R; Seferovic P; Edvardsen T; Lyon AR
    Eur J Heart Fail; 2020 Sep; 22(9):1504-1524. PubMed ID: 32621569
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Interventional cardiology in cancer patients: A position paper from the Portuguese Cardiovascular Intervention Association and the Portuguese Cardio-Oncology Study Group of the Portuguese Society of Cardiology.
    Nobre Menezes M; Tavares da Silva M; Magalhães A; Melica B; Toste JC; Calé R; Almeida M; Fiuza M; Infante de Oliveira E
    Rev Port Cardiol; 2024 Jan; 43(1):35-48. PubMed ID: 37482119
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Recent advances in cardio-oncology: a report from the 'Heart Failure Association 2019 and World Congress on Acute Heart Failure 2019'.
    Anker MS; Hadzibegovic S; Lena A; Belenkov Y; Bergler-Klein J; de Boer RA; Farmakis D; von Haehling S; Iakobishvili Z; Maack C; Pudil R; Skouri H; Cohen-Solal A; Tocchetti CG; Coats AJS; Seferović PM; Lyon AR;
    ESC Heart Fail; 2019 Dec; 6(6):1140-1148. PubMed ID: 31884717
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Emergence of cardio-oncology.
    Nebigil CG; Désaubry L
    Ann Pharm Fr; 2018 Nov; 76(6):504-506. PubMed ID: 30075937
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Molecular biomarkers in cardio-oncology: Where we stand and where we are heading.
    Vasileiou PVS; Siasos G; Gorgoulis VG
    Bioessays; 2022 Jun; 44(6):e2100234. PubMed ID: 35352831
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Predictability of cardiotoxicity: Experience of a Belgian cardio-oncology clinic.
    Jacobs JEJ; Guler I; Duchenne J; Janssens S; Van Aelst LNL
    Int J Cardiol; 2022 Sep; 363():119-122. PubMed ID: 35777489
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Editorial commentary: Searching for the sweet spot of cardioprotection in cancer treatment related cardiotoxicity: Who will benefit?
    Cheng RK; Yang EH
    Trends Cardiovasc Med; 2020 Jan; 30(1):29-31. PubMed ID: 30797696
    [No Abstract]   [Full Text] [Related]  

  • 78. Modeling Precision Cardio-Oncology: Using Human-Induced Pluripotent Stem Cells for Risk Stratification and Prevention.
    Perry TR; Roberts ML; Sunkara B; Maddula R; McLeish T; Gomez J; Lucas J; Rayan D; Patel S; Liang M; Bosnjak ZJ; Brown SA
    Curr Oncol Rep; 2021 May; 23(7):77. PubMed ID: 33937943
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [2022 ESC guidelines on cardio-oncology : Understanding and treating cardiovascular side effects from cancer therapy].
    Michel L; Totzeck M; Rassaf T
    Herz; 2023 Feb; 48(1):15-22. PubMed ID: 36441175
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Modern concepts in cardio-oncology.
    Rassaf T; Totzeck M
    J Thorac Dis; 2018 Dec; 10(Suppl 35):S4386-S4390. PubMed ID: 30701105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.